Patents by Inventor Kegang CHEN

Kegang CHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11618766
    Abstract: Disclosed in the present disclosure is a method for preparing 16alpha-hydroxyprednisolone, belonging to the technical field of medicine preparation and processing. In the method, 21-hydroxypregna-1,4,9(11),16-tetraene-3,20-dione-21-acetate is used as a starting material, and subjected to oxidation, bromo-hydroxylation, debromination and alcoholysis, so as to prepare 16alpha-hydroxyprednisolone. The method for preparing 16alpha-hydroxylprednisolone of the present disclosure can effectively control the generation of impurities in the reaction process by improving the disadvantages of traditional processes, and has a mild reaction process and a high overall conversion rate; and the method of the present disclosure has low requirements for a reaction device and low operation costs, is easy to operate, is suitable for industrial production, and has a good market prospect.
    Type: Grant
    Filed: September 20, 2022
    Date of Patent: April 4, 2023
    Assignee: ZHEJIANG SHENZHOU PHARMACEUTICAL COMPANY LIMITED
    Inventors: Zhenping Shao, Rong Wang, Kegang Chen, Bingqian Wang, Youfu Wang
  • Publication number: 20230028248
    Abstract: Disclosed in the present disclosure is a method for preparing 16alpha-hydroxyprednisolone, belonging to the technical field of medicine preparation and processing. In the method, 21-hydroxypregna-1,4,9(11),16-tetraene-3,20-dione-21-acetate is used as a starting material, and subjected to oxidation, bromo-hydroxylation, debromination and alcoholysis, so as to prepare 16alpha-hydroxyprednisolone. The method for preparing 16alpha-hydroxylprednisolone of the present disclosure can effectively control the generation of impurities in the reaction process by improving the disadvantages of traditional processes, and has a mild reaction process and a high overall conversion rate; and the method of the present disclosure has low requirements for a reaction device and low operation costs, is easy to operate, is suitable for industrial production, and has a good market prospect.
    Type: Application
    Filed: September 20, 2022
    Publication date: January 26, 2023
    Applicant: ZHEJIANG SHENZHOU PHARMACEUTICAL COMPANY LIMITED
    Inventors: Zhenping SHAO, Rong WANG, Kegang CHEN, Bingqian WANG, Youfu WANG